EXACT SCIENCES CORP (EXAS) Inventory (2014 - 2025)

Exact Sciences (EXAS) has reported Inventory for 12 consecutive years, with $166.2 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Inventory rose 2.35% year-over-year to $166.2 million in Q4 2025; TTM through Dec 2025 was $166.2 million, a 2.35% increase from a year earlier, with the FY2025 full-year figure at $166.2 million, up 2.35% from the prior year.
• Inventory was $166.2 million for Q4 2025 at Exact Sciences, up from $164.8 million in the prior quarter.
• Over five years, Inventory peaked at $176.6 million in Q1 2025 and troughed at $89.0 million in Q1 2021.
• A 5-year average of $129.5 million and a median of $127.4 million in 2023 frame the typical range for Inventory.
• Across the five-year window, Inventory decreased 2.6% in 2024 and soared 37.38% in 2025, its largest moves.
• Over 5 years, Inventory stood at $105.0 million in 2021, then grew by 12.63% to $118.3 million in 2022, then advanced by 7.79% to $127.5 million in 2023, then grew by 27.38% to $162.4 million in 2024, then rose by 2.35% to $166.2 million in 2025.
• The last three Inventory figures came in at $166.2 million (Q4 2025), $164.8 million (Q3 2025), and $171.5 million (Q2 2025), per Business Quant data.